CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Operating cash flow, 2025
- $738M
- YoY, 2025
- +0.4%
- 5-year CAGR
- +6.2%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $738M | +0.4% |
| 2024 | $735M | +7.4% |
| 2023 | $684M | +10.4% |
| 2022 | $620M | −18.6% |
| 2021 | $761M | +39.2% |
| 2020 | $547M | +13.6% |
| 2019 | $481M | +9.0% |
| 2018 | $441M | +38.7% |
| 2017 | $318M | +0.4% |
| 2016 | $317M | — |